A pseudovirus-based method to dynamically mimic SARS-CoV-2-associated cell-to-cell fusion and transmission

Xiangpeng Sheng; Yi Yang; Fang Zhu; Fan Yang; Honghua Wang; Ronggui Hu

doi:10.3724/abbs.2023129

A pseudovirus-based method to dynamically mimic SARS-CoV-2-associated cell-to-cell fusion and transmission

Acta Biochim Biophys Sin (Shanghai). 2023 Nov 25;55(11):1840-1843. doi: 10.3724/abbs.2023129.

Authors

Xiangpeng Sheng^{1

2

3}, Yi Yang⁴, Fang Zhu⁵, Fan Yang², Honghua Wang¹, Ronggui Hu^{1

2}

Affiliations

¹ Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
² State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai 200031, China.
³ State Key Laboratory of Animal Disease Control, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.
⁴ Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China.
⁵ School of Medicine, Guizhou University, Guiyang 550025, China.

No abstract available

MeSH terms

Antibodies, Viral
COVID-19*
Cell Fusion
Cell Line
Humans
SARS-CoV-2*

Substances

Antibodies, Viral

Grants and funding

This work was supported by the grants from the Ministry of Science and Technology of China (Nos. 2019YFA0802103 and 2021ZD0203900), the Department of Science and Technology of Zhejiang Province (No. 2021C03104), the Guangzhou Science Innovation and Development Program (No. 201803010092), the Shenzhen-Hong Kong Institute of Brain Science (No. NYKFKT2019006), and the National Natural Science Foundation of China (No. 92253302).